German Scoliosis Center Bad Wildungen, Im Kreuzfeld 4, 34537, Bad Wildungen, Germany.
Eur Spine J. 2011 Aug;20 Suppl 3(Suppl 3):397-402. doi: 10.1007/s00586-011-1906-3. Epub 2011 Jul 26.
Surgical site infection (SSI) can be a challenging complication after posterior spinal fusion and instrumentation (PSFI). An increasing rate of SSI by gram-negative bacteria (GNB) has been observed. Current guideline recommendations have not been effective for preventing infection by these microorganisms.
Retrospective cohort study comparing two consecutive groups of patients undergoing PSFI at a single institution. Cohort A includes 236 patients, operated between January 2006 and March 2007, receiving standard preoperative antibiotic prophylaxis with cefazolin (clindamycin in allergic patients). Cohort B includes 223 patients operated between January and December 2009, receiving individualized antibiotic prophylaxis and treatment based on preoperative urine culture. Cultures were done 3-5 days before surgery in patients meeting one of the following risk criteria for urinary tract colonization: hospitalization longer than 7 days, indwelling catheter, neurogenic bladder, history of urinary incontinence, or history of recurrent urinary tract infection.
Twenty-two (9.3%) patients in cohort A developed SSI, 68.2% due to GNB. 38 (17%) patients in cohort B were considered at risk for GNB colonization; preoperative urine culture was positive in 14 (36%). After adjusted antibiotic prophylaxis, 15 (6.27%) patients in cohort B developed SSI, 33.4% due to GNB. A statistically significant reduction in GNB SSI was seen in cohort B (Fisher's exact test, p = 0.039).
Higher preoperative GNB colonization rates were found in patients with neurogenic bladder or indwelling catheters. Preoperative bacteriological screening, treatment for bacteriuria, and individualized antibiotic prophylaxis were effective for reducing GNB SSI.
脊柱后路融合内固定术后发生手术部位感染(SSI)是一个棘手的并发症。革兰氏阴性菌(GNB)引起的 SSI 发生率呈上升趋势。目前的指南推荐对于预防这些微生物感染并不有效。
本研究为单中心回顾性队列研究,比较了两组连续接受脊柱后路融合内固定术的患者。A 队列纳入 2006 年 1 月至 2007 年 3 月期间手术的 236 例患者,接受头孢唑啉(过敏患者用克林霉素)标准术前抗生素预防。B 队列纳入 2009 年 1 月至 12 月期间手术的 223 例患者,接受基于术前尿培养的个体化抗生素预防和治疗。在符合以下 1 项或多项下尿路定植风险标准的患者中,在术前 3-5 天进行培养:住院时间超过 7 天、留置导尿管、神经源性膀胱、尿失禁史或复发性尿路感染史。
A 队列中有 22 例(9.3%)患者发生 SSI,其中 68.2%由 GNB 引起。B 队列中有 38 例(17%)患者存在 GNB 定植风险;14 例(36%)患者术前尿培养阳性。经过调整抗生素预防后,B 队列中有 15 例(6.27%)患者发生 SSI,其中 33.4%由 GNB 引起。B 队列中 GNB SSI 发生率显著降低(Fisher 精确检验,p=0.039)。
存在神经源性膀胱或留置导尿管的患者下尿路 GNB 定植率更高。术前细菌学筛查、治疗菌尿症和个体化抗生素预防可有效降低 GNB SSI 发生率。